PSPinak B. Shah

Pinak B. Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pinak B. Shah has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Alistair Phillips

    American College of Cardiology Cardiac Surgery Team and Leadership Council, Washington, DC; The Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio

    1 shared publication
  • David Fullerton

    American College of Cardiology Cardiac Surgery Team and Leadership Council, Washington, DC; Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Denver, Colorado

    1 shared publication
  • Dee Dee Wang

    Henry Ford Health System, Center for Structural Heart Disease, Wayne State University School of Medicine, Detroit, Michigan

    1 shared publication
  • Ehtisham Mahmud

    Society for Cardiovascular Angiography and Interventions, Washington, DC; Division of Cardiovascular Medicine, University of California-San Diego, San Diego, California

    1 shared publication
  • Frederick G.P. Welt

    American College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Cardiovascular Division, University of Utah Health, Salt Lake City, Utah

    1 shared publication
  • James Hermiller

    Society for Cardiovascular Angiography and Interventions, Washington, DC; Ascension Medical Group, Indianapolis, Indiana

    1 shared publication

Latest Publications

  • Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic

    by Pinak B. Shah, Frederick G.P. Welt, Ehtisham Mahmud, Alistair Phillips, Neal S. Kleiman, Michael N. Young, Matthew Sherwood, Wayne Batchelor, Dee Dee Wang, Laura Davidson, et al.


  • Percutaneous Closure of a Delayed Left Ventricular Pseudoaneurysm After Transseptal Transcatheter Mitral Valve Replacement

    by Neal Sawlani, Natalia Berry, Piotr Sobieszczyk, Tsuyoshi Kaneko, Marc Pelletier, Pinak Shah


  • Management of Coronary Chronic Total Occlusion

    by Pinak B. Shah

    A 67-year-old man with chronic stable angina presented with worsening angina to class III despite maximal medical therapy. He was referred for myocardial perfusion imaging, which showed a large area of inferior ischemia. Subsequent coronary angiography revealed a chronic total occlusion (CTO) of the right coronary artery with brisk collateral flow from the left anterior descending artery (Figure 1). There was minimal obstructive disease in the remainder of the coronary tree. An attempt at percutaneous coronary intervention (PCI) was unsuccessful. He was treated with continuation of his medical therapy, although he remained with lifestyle-limiting class II to III angina. Figure 1. Left, The totally occluded right coronary artery with the expected course of the distal vessel outlined in red and the total occlusion shown by the arrow. Right, Collateralization of the right coronary artery from the left anterior descending (LAD) artery with arrows pointing to the posterior descending artery (PDA) and posterolateral ventricular (PLV) branches of the right coronary artery. The septal collaterals from the LAD to RCA are highlighted. Coronary CTO is characterized by heavy atherosclerotic plaque burden within the artery, resulting in complete (or nearly complete) occlusion of the vessel. Although the duration of the occlusion is difficult to determine on clinical grounds, a total occlusion must be present for at least 3 months to be considered a true CTO.1 Patients with CTO typically have collateralization of the distal vessel on coronary angiography, but these collaterals may not provide sufficient blood flow to the myocardial bed, resulting in ischemia and anginal symptoms. CTO is clinically distinct from acute coronary occlusion, which occurs in the setting of ST-segment–elevation myocardial infarction, or subacute coronary occlusion, discovered with delayed presentation after ST-segment–elevation myocardial infarction. Clinical features and treatment considerations of these entities differ considerably from CTO. Among patients who have a clinical …